Close

Pre-Open Stock Movers 9/5: (ENVI) (KDN) (FCEL) Higher; (AGEN) (CONN) (BV) Lower (more...)

September 5, 2013 9:37 AM EDT Send to a Friend
Agenus Inc. (Nasdaq: AGEN) 33.7% LOWER; announced that GlaxoSmithKlines (NYSE: GSK) DERMAi study, a Phase 3 randomized, blinded, placebo-controlled MAGE-A3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login